Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 8.635.795.754.703.37

What is the latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS is 8.63 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20248.63
Mar20235.79
Mar20225.75
Mar20214.70
Mar20203.37

How is EV/Core EBITDA of LINCOLN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 8.63
49.05
Mar2023 5.79
0.70
Mar2022 5.75
22.34
Mar2021 4.7
39.47
Mar2020 3.37 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,093.4 Cr -0.2% -4.5% -6.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,865.0 Cr -0.5% -8.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹173,574.0 Cr -2.4% 7.2% 50.6% Stock Analytics
CIPLA ₹118,710.0 Cr -0.7% -3.7% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,964.0 Cr -1.4% -3.9% 19% Stock Analytics
DR REDDYS LABORATORIES ₹104,232.0 Cr 0.5% 5.6% 5.1% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-0.2%

-4.5%

-6.6%

SENSEX

-1%

1.4%

7.9%


You may also like the below Video Courses